Back to User profile » Dr Huilin Wang
Papers published by Dr Huilin Wang:
Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy
Yuan C, Huang M, Wang H, Jiang W, Su C, Zhou S
Cancer Management and Research 2022, 14:377-386
Published Date: 26 January 2022
Comparison of Different EGFR Gene Mutation Status in Patients with Metastatic Non-Small Lung Cancer After First-Line EGFR-TKIs Therapy and Analyzing Its Relationship with Efficacy and Prognosis
Yuan C, Jiang H, Jiang W, Wang H, Su C, Zhou S
Cancer Management and Research 2021, 13:6901-6910
Published Date: 3 September 2021
STRN-ALK Fusion in Lung Adenocarcinoma with Excellent Response Upon Alectinib Treatment: A Case Report and Literature Review
Su C, Jiang Y, Jiang W, Wang H, Liu S, Shao Y, Zhao W, Ning R, Yu Q
OncoTargets and Therapy 2020, 13:12515-12519
Published Date: 4 December 2020
Prognostic Value of Pretreatment Albumin-to-Alkaline Phosphatase Ratio in Extensive-Disease Small-Cell Lung Cancer: A Retrospective Cohort Study
Zhou S, Wang H, Jiang W, Yu Q, Zeng A
Cancer Management and Research 2020, 12:2015-2024
Published Date: 18 March 2020
Clinicopathological Characteristics And EGFR-TKIs Efficacies In Lung Squamous Cell Carcinoma Patients Harboring An EGFR Sensitizing Mutation
Zhou S, Wang H, Jiang W, Yu Q
OncoTargets and Therapy 2019, 12:8863-8871
Published Date: 30 October 2019